Breast Biopsy Market Regional Analysis:
APAC Market Insights
The breast biopsies market in Asia Pacific is expected to hold around 35% share by the end of 2034. The growth of the region is due to increase in the percentage of the aging population. As older women have a higher risk of breast cancer. Also, health organizations are increasingly promoting breast cancer screening programs, including mammograms and breast biopsies.
North America Market Insights
The breast biopsy market in the North America is expected to account for 25% revenue share by 2034, attributed to increasing technological advancement in breast biopsy technology in the region. There have been significant advances in the design and function of biopsy needles and other biopsy devices in North America, making breast biopsies more precise and less invasive. This has led to an increase in demand for breast biopsy procedures in the region. All insurance plans in North America cover breast biopsy procedures, making the procedure easier for patients to access, leading to increased demand.
